STT-Module 4
STT-Module 4
1
Objectives
Make decisions and actions on each of the
national flow-charts
Use the national flow-charts to make a
syndromic diagnosis for a variety of STIs
cases
List the correct drug therapies and
dosages for each diagnosis
Make arrangements for a follow – up visit
2
Urethral
Discharge
3
Agents
Most common:
- Neisseria gonorrhoea
• Acute onset with profuse and purulent
discharge
- Chlamydia trachomatis
• Sub acute onset with scant mucopurulent
discharge
But this is not always true and mixed infections
are common and
2nd most common:
- Trichomonas vaginalis 4
Rare agents
Rarely:
- Mycoplasma genitalium
- Ureaplasma uraelyticum
5
Clinical Presentation
Burning sensation on urination,
dysuria
Urethral discharge
Meatal excoriation
6
Complications
Local spread and Dissemination
Stricture and infertility
7
Urethral discharge
8
Urethral discharge
complains of urethral discharge
or dysuria
PLUS
12
Genital ulcer
13
Vesicular
HSV2: Genital Herps
Non-Vesicualr
T. Pallidum: Syphilis
H. Ducreyi: Chancroid
C. Trachomatis Serovars L1-L3: LGV
K.Granulomatis (C. Granulomatis): Granuloma
ingunale 14
Syphilis
Acute and Chronic infection caused by T.
pallidum
Transmission: Sexual, MTC & contaminated
blood
Incubation period 21 days ( 10-90 days and
depends on inoculum's dose)
Diverse presentation
15
Primary syphilis
Solitary genital ulcer
- Non tender hard ulcer
- Painless inguinal adenopathy
16
Syphilis cont’d
Secondary syphilis
- Disseminated spirochetemia
- 8 weeks after infection
- Skin rash is common feature
- Alopecia ; moth-eaten appearance
- Atypical facial plaques
- Mucosal ulcerations
- Condylomata lata
- Painless generalized lymphadenopathy
17
Secondary Latent syphilis
where there are no clinical signs but
syphilis serology is reactive
18
Tertiary syphilis
- Gumma
- Cardiovascular: aortitis leading to
valve incompetence and aneurysm
- Neuro-syphilis
19
Neurosyphilis
• Stroke like presentation ( meningovascular)
• Asymptomatic but positive VDRL on CSF
• Tabes dorsalis
• Paralysis of the insane
• Cranial palsy (cranial nerve VIII, III, optic
atrophy)
20
Chancroid
Lesions are painful, progressing from a small
papule to pustule and then to ulcer with soft
margins described as soft chancre
Inguinal adenopathy that becomes necrotic
and fluctuant (buboes) follow the ulcer
Not found to be a common cause of genital
ulcer syndrome in the validation study
The incubation period is usually 2-10 days
Transmitted exclusively by sexual contact
A cofactor for HIV transmission; high rates of
HIV infection among patients
21
Lymphogranuloma Venereum
(LGV)
Caused by C. trachomatis serovars L1, L2, or L3.
LGV primarily infects the lymphatics
Most common clinical manifestation is tender
inguinal and/or femoral lymphadenopathy - most
commonly unilateral
Women and homosexually active men may have
proctocolitis or inflammatory involvement of
perirectal or perianal lymphatic tissues resulting
in fistulas and strictures
22
Lymphogranuloma Venereum
(LGV)
A self-limited genital ulcer sometimes
occurs at the site of inoculation
By the time patients seek care, the
ulcer usually has disappeared
There is little information on the
prevalence of LGV as a cause of genital
ulcer in Ethiopia.
23
Granuloma inguinale
Chronically progressive ulcerative disease
without systemic symptoms
The etiologic agent is Calymmatobacterium
granulomatis
Incubation period generally is 1-4 weeks,
may be up to 1 year
It is transmitted primarily by sexual contact
There is little information on the prevalence
of Donovanosis as a cause of genital ulcer in
Ethiopia.
24
Complications of GU
Disease Etiology Complications
ulcers healed No
ulcers improved Refer
Yes
•Educate & provide
condoms Continue Rx
•Offer HIV testing 26
Figure 3
•Consider episodic Rx
Recommended treatment
29
Common causes of vaginal discharge
Sexually transmitted
Neisseria gonorrhoeae4
Chlamydia trachomatis5
Trichomonas vaginalis3
Endogenous infection
Gardnerella vaginalis1 (bacterial Vaginosis)
Homogenous discharge with typical fishy odor (due to presence of volatile
amines)
Candida albicans 2
Cheese-like odorless discharge (may vary from watery to homogenous
30
thick discharge
Initial evaluation of patients
with vaginal discharge include
Risk assessment
Age less than 25 years
Having multiple sexual partner in the last three
months
Having new partner in the last three months
Having ever traded for sex
VAGINITIS CERVICITIS
Trichomoniasis, candidiasis, Gonorrhea & chlamydia
bacterial vaginosis
Influenza
37
Diagnosis of PID
Diagnosis is often difficult & inconsistent clinical
presentations are common
Bilateral or unilateral lower abdominal pain (except
endometritis) & vaginal discharge support diagnosis
History
P. Exam:
temperature
Erratic bleeding
Recent delivery
tenderness, guarding & mass
vaginal bleeding &
Miscarriage
abnormal discharge
38
Complications of PID
Peritonitis and intra-abdominal abscess
Adhesion and intestinal obstruction
Ectopic pregnancy
Infertility
Chronic pelvic pain
39
complains of lower abdominal pain
improved? No Refer
Ye patient for
• Refer patient
s for Yes
surgical or admission
• Continue treatment
gynaecological
assessment • Educate on RR
• set up IV line • Offer HCT
• Condom use 40
• Resuscitate if Figure 9
Recommended treatment
Out patient in patent
Ciprofloxacin tablet 500 mg po Ceftriaxone 250 mg IV/IM daily
stat
OR OR
Spectinomycin 2 gm im stat Spectinomycin 2 gm im bid
Plus Plus
Doxycycline tablet 100 mg po bid Doxycycline 100 mg bid for 14
for 14 days days
Plus Plus
Metronidazole 500 mg bid for 14 Metronidazole 500 mg bid for 14
days days or chloramphenicol 500 mg
Admit if there is no improvement IV qid.
within 72 hours
41
Indications for hospitalizations
in PID
Uncertain diagnosis
Acute abdomen can not be excluded
Pelvic abscess is suspected
Severe illness precludes management on an
outpatient basis
Pregnancy
The patient is unable to follow or tolerate an
outpatient regimen
The patient has failed to respond to
outpatient therapy
42
Scrotal
Swelling
43
Scrotal swelling
Painful testis/ epididymis
44
Presentation
Clinical presentations
Testicular infarction and atrophy
Abscess formation
Chronic epididymitis
Complications
Epididymitis
Infertility
Impotence
Prostatitis
45
complains of scrotal
swelling/pain
49
Inguinal Bubo
51
Inguinal Bubo
Men affected more than females
Complications:
Abscess formation and PID
Lymphatic obstruction
52
complains of inguinal
swelling
Plus
54
Neonatal
Conjunctivitis
55
Neonatal Conjuctivitis
pregnancy
Avoiding exposure of the infection to herpetic lesions
during delivery
In women with active genital herpetic lesions
•Reassure mother
Bilateral or No •Advise to return
unilateral swollen if necessary
eyelids with
purulent
discharge
Yes
Yes
Rx child & mother for GC
& Chlamydia
•For mother only:
•Educate on RR Improved
•Provide condoms No
•Offer HIV testing Refer
•Advise to return in 60
Recommended treatment
for neonatal herpes
Acyclovir 10 mg /Kg IV three times
daily for 14 days for localized mucosal
or dermal infections
61
Remarks on drugs used for
STI treatment
Erythromycin should be taken on an
empty stomach because bio availability is
affected by food, GI upset is a
recognized side effect
Ciprofloxacin should not be given to
pregnant women or children
Spectinomycin could cause renal damage
and requires parentral administration
62
Remarks on drugs used for
STI treatment
Ceftriaxone is expensive and may not be
available
Doxycyclin & Tetracyclin contraindicated in
pregnant women and children
Tetracyclin should not be taken with milk
Acyclovir the only drug available for treatment
of herpes in Ethiopia. It is safe and can be
used during pregnancy. Acyclovir cream is not
effective for treatment of genital herpes
63
Introduction to Pre-packaged
STI Treatment Kits (samples)
Contents:
- antibiotics (genital ulcers and urethral
discharge)
- condoms
- instruction booklet
- partner notification cards
- special warning pamphlet
- additional elements for injections (genital
ulcers)
64
Flow-chart for Follow up visit
65
Follow –up visit for patients
with STIs
Importance of follow up visit:
- ensure care & exclude incubating STIs
particularly syphyllis
- some patients may not respond to initial
treatment & reassessment may be needed
- the response to treatment may not be
dramatic with concomitant HIV
- VCT could be offered during follow up
visit
66
Group work!!!!
67
STIs
68